CytomX Therapeutics, Inc. Quarterly Unrecognized Tax Benefits in USD from Q4 2012 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of unrecognized tax benefits.
Summary
CytomX Therapeutics, Inc. quarterly Unrecognized Tax Benefits history and growth rate from Q4 2012 to Q4 2023.
  • CytomX Therapeutics, Inc. Unrecognized Tax Benefits for the quarter ending December 31, 2023 was $19.4M, a 109% increase year-over-year.
Unrecognized Tax Benefits, Quarterly (USD)
Unrecognized Tax Benefits, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2023 $19.4M +$10.1M +109% Dec 31, 2023 10-K 2024-03-11
Q4 2022 $9.27M +$1.49M +19.1% Dec 31, 2022 10-K 2024-03-11
Q4 2021 $7.78M +$1.33M +20.5% Dec 31, 2021 10-K 2024-03-11
Q4 2020 $6.45M +$1.21M +23% Dec 31, 2020 10-K 2023-03-27
Q4 2019 $5.25M +$1.49M +39.8% Dec 31, 2019 10-K/A 2023-03-27
Q4 2018 $3.76M -$564K -13.1% Dec 31, 2018 10-K/A 2023-03-27
Q4 2017 $4.32M +$3.14M +265% Dec 31, 2017 10-K 2021-02-24
Q4 2016 $1.18M +$516K +77.5% Dec 31, 2016 10-K 2020-02-27
Q4 2015 $666K -$2.35M -77.9% Dec 31, 2015 10-K 2019-02-27
Q4 2014 $3.02M +$2.49M +467% Dec 31, 2014 10-K 2018-03-07
Q4 2013 $532K +$332K +166% Dec 31, 2013 10-K 2017-03-02
Q4 2012 $200K Dec 31, 2012 10-K 2016-03-07
* An asterisk sign (*) next to the value indicates that the value is likely invalid.